Phase II study of gefitinib and inserted cisplatin plus docetaxel as a first-line treatment for advanced non-small cell lung cancer haboring an epidermal growth factor receptor activating mutation

被引：0

作者：

Kanda, Shintaro

Ohe, Yuichiro

Horinouchi, Hidehito

Fujiwara, Yutaka

Nokihara, Hiroshi

Yamamoto, Noboru

Sekine, Ikuo

Kunitoh, Hideo

Kubota, Kaoru

Tamura, Tomohide

机构：

[1] Natl Canc Ctr, Div Thorac Oncol, Tokyo, Japan

[2] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan

[3] Chiba Univ, Dept Med Oncol, Chiba, Japan

[4] Mitsui Mem Hosp, Dept Resp Med, Tokyo 101, Japan

[5] Nippon Med Coll Hosp, Div Pulm Med Infect & Oncol, Dept Internal Med, Tokyo, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8064

引用

页数：1